CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy President bought 5,922 shares at an average $0.08 ($494)
- 4 Open-market buy President bought 3,800 shares at an average $0.09 ($334)
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 4 Open-market buy President bought 14,641 shares at an average $0.09 ($1,378)
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-A12G Other 8-A12G
- 10-Q/A Report 10-Q/A
Page 22 of 26 · 502 filings